Literature DB >> 25189732

Direct and indirect costs associated to type 2 diabetes and its complications measured in a social security institution of Argentina.

Jorge F Elgart1, Santiago Asteazarán, Jorge L De La Fuente, Cecilia Camillucci, Jonathan B Brown, Juan José Gagliardino.   

Abstract

OBJECTIVES: To estimate direct and indirect costs of care of type 2 diabetes (T2DM) and its complications in Argentina, and compare them with those recorded in people without diabetes (ND).
METHODS: Observational retrospective case-control study performed in one institution of the Social Security System of Argentina. Participants were identified and randomly selected from the Institution's electronic medical records. We recruited persons with T2DM with (387) or without (387) chronic complications and 774 ND, matched by age and gender. Data were obtained by telephone interviews and supplemented with data from the Institution's records. Parametric and non-parametric tests were used for group comparisons.
RESULTS: Direct costs were higher in people with T2DM than in ND: twice as high in people with T2DM without complications and 3.6 times in those with complications. Absenteeism was only higher in T2DM with complications, but there were no differences among groups either in the duration or in the cost of such absenteeism.
CONCLUSIONS: T2DM and the development of its complications are positively associated with higher direct costs in Argentina.

Entities:  

Mesh:

Year:  2014        PMID: 25189732     DOI: 10.1007/s00038-014-0604-4

Source DB:  PubMed          Journal:  Int J Public Health        ISSN: 1661-8556            Impact factor:   3.380


  24 in total

1.  Global healthcare expenditure on diabetes for 2010 and 2030.

Authors:  Ping Zhang; Xinzhi Zhang; Jonathan Brown; Dorte Vistisen; Richard Sicree; Jonathan Shaw; Gregory Nichols
Journal:  Diabetes Res Clin Pract       Date:  2010-02-19       Impact factor: 5.602

2.  Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs.

Authors:  N Hex; C Bartlett; D Wright; M Taylor; D Varley
Journal:  Diabet Med       Date:  2012-07       Impact factor: 4.359

3.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

4.  Estimating the cost of illness.

Authors:  D P Rice
Journal:  Am J Public Health Nations Health       Date:  1967-03

5.  National trends in treatment of type 2 diabetes mellitus, 1994-2007.

Authors:  G Caleb Alexander; Niraj L Sehgal; Rachael M Moloney; Randall S Stafford
Journal:  Arch Intern Med       Date:  2008-10-27

6.  Assessing the impact of complications on the costs of Type II diabetes.

Authors:  R Williams; L Van Gaal; C Lucioni
Journal:  Diabetologia       Date:  2002-06-12       Impact factor: 10.122

7.  Clinical, metabolic and psychological outcomes and treatment costs of a prospective randomized trial based on different educational strategies to improve diabetes care (PRODIACOR).

Authors:  J J Gagliardino; S Lapertosa; G Pfirter; M Villagra; J E Caporale; C D Gonzalez; J Elgart; L González; C Cernadas; E Rucci; C Clark
Journal:  Diabet Med       Date:  2013-06-07       Impact factor: 4.359

8.  Economic costs of diabetes in the U.S. in 2012.

Authors: 
Journal:  Diabetes Care       Date:  2013-03-06       Impact factor: 19.112

9.  Health disparities from economic burden of diabetes in middle-income countries: evidence from México.

Authors:  Armando Arredondo; Gabriela Reyes
Journal:  PLoS One       Date:  2013-07-12       Impact factor: 3.240

Review 10.  Diabetes in Argentina: cost and management of diabetes and its complications and challenges for health policy.

Authors:  Joaquín E Caporale; Jorge F Elgart; Juan J Gagliardino
Journal:  Global Health       Date:  2013-10-29       Impact factor: 4.185

View more
  8 in total

1.  Prevalence, diagnosis, and management of diabetes mellitus among older Chinese: results from the China Health and Retirement Longitudinal Study.

Authors:  Yaohui Zhao; Eileen M Crimmins; Peifeng Hu; Yang Shen; James P Smith; John Strauss; Yafeng Wang; Yuan Zhang
Journal:  Int J Public Health       Date:  2016-01-11       Impact factor: 3.380

2.  The burden of diabetes in Argentina.

Authors:  Lorena Gonzalez; Joaquin E Caporale; Jorge F Elgart; Juan J Gagliardino
Journal:  Glob J Health Sci       Date:  2014-11-17

3.  The cost of diabetes in Latin America and the Caribbean in 2015: Evidence for decision and policy makers.

Authors:  Alberto Barcelo; Armando Arredondo; Amparo Gordillo-Tobar; Johanna Segovia; Anthony Qiang
Journal:  J Glob Health       Date:  2017-12       Impact factor: 4.413

4.  Direct and indirect costs of diabetes mellitus in Mali: A case-control study.

Authors:  Clara Bermudez-Tamayo; Stéphane Besançon; Mira Johri; Sidibe Assa; Jonathan Betz Brown; Kaushik Ramaiya
Journal:  PLoS One       Date:  2017-05-18       Impact factor: 3.240

5.  Factors of occurrence and improvement methods of presenteeism attributed to diabetes: A systematic review.

Authors:  Koji Mori; Takahiro Mori; Tomohisa Nagata; Masako Nagata; Mahoko Iwasaki; Hiroki Sakai; Koki Kimura; Natsumi Shinzato
Journal:  J Occup Health       Date:  2019-01       Impact factor: 2.708

6.  The costs of diabetes treatment in low- and middle-income countries: a systematic review.

Authors:  Corrina Moucheraud; Cosima Lenz; Michaella Latkovic; Veronika J Wirtz
Journal:  BMJ Glob Health       Date:  2019-02-27

7.  Dyslipidemia: The untreated metabolic dysfunction in people with type 2 diabetes in Latin America. ARETAEUS study outcomes.

Authors:  Juan José Gagliardino; Rosario Arechavaleta; Freddy Goldberg Eliaschewitz; Kristy Iglay; Kimberly Brodovicz; Claudio D Gonzalez; Shengsheng Yu; R Ravi Shankar; Olaf Heisel; Paul Keown; Kaan Tunceli
Journal:  J Clin Transl Endocrinol       Date:  2019-01-25

Review 8.  Health Literacy in the Population of Diabetic Patients in Iran: A Systematic Review and Meta-Analysis.

Authors:  Marjan Momeni; Majid Mirmohammadkhani; Abbas Ziari
Journal:  Iran J Public Health       Date:  2020-04       Impact factor: 1.429

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.